Abnormal apelin-ACE2 and SGLT2 signaling contribute to adverse cardiorenal injury in patients with COVID-19
出版年份 2021 全文链接
标题
Abnormal apelin-ACE2 and SGLT2 signaling contribute to adverse cardiorenal injury in patients with COVID-19
作者
关键词
Angiotensin converting enzyme 2, Apelin, Severe acute respiratory syndrome coronavirus 2, COVID-19, SGLT2 inhibitor, Inflammation
出版物
INTERNATIONAL JOURNAL OF CARDIOLOGY
Volume -, Issue -, Pages -
出版商
Elsevier BV
发表日期
2021-05-15
DOI
10.1016/j.ijcard.2021.05.029
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Mechanisms of Cardiorenal Effects of Sodium-Glucose Cotransporter 2 Inhibitors
- (2020) Thomas A. Zelniker et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury
- (2020) Yingxia Liu et al. Science China-Life Sciences
- Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2
- (2020) Vanessa Monteil et al. CELL
- Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System
- (2020) Mahmoud Gheblawi et al. CIRCULATION RESEARCH
- Multiorgan and Renal Tropism of SARS-CoV-2
- (2020) Victor G. Puelles et al. NEW ENGLAND JOURNAL OF MEDICINE
- Apelin/Elabela-APJ: a novel therapeutic target in the cardiovascular system
- (2020) Wei Liu et al. Annals of Translational Medicine
- Apelin-potential therapy for COVID-19?
- (2020) Seyed Soheil Saeedi Saravi et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Myocardial injury and COVID-19: Possible mechanisms
- (2020) Savalan Babapoor-Farrokhran et al. LIFE SCIENCES
- SGLT2 inhibitors: mechanisms of cardiovascular benefit beyond glycaemic control
- (2020) Martin R. Cowie et al. Nature Reviews Cardiology
- COVID-19, Renin-Angiotensin System and Endothelial Dysfunction
- (2020) Razie Amraei et al. Cells
- ACE/ACE2 Ratio: A Key Also in 2019 Coronavirus Disease (Covid-19)?
- (2020) Pasquale Pagliaro et al. Frontiers in Medicine
- Heart failure in COVID‐19 patients: prevalence, incidence and prognostic implications
- (2020) Juan R. Rey et al. EUROPEAN JOURNAL OF HEART FAILURE
- Nephrology and COVID-19
- (2020) Wolfgang C. Winkelmayer et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure
- (2020) Milton Packer et al. NEW ENGLAND JOURNAL OF MEDICINE
- COVID-19 can affect the heart
- (2020) Eric J. Topol SCIENCE
- Cytokine storm and COVID-19: a chronicle of pro-inflammatory cytokines
- (2020) Antonella Fara et al. Open Biology
- Increased plasma ACE2 concentration does not mean increased risk of SARS-CoV-2 infection and increased fatality rate of COVID-19
- (2020) Xueting Li et al. Acta Pharmaceutica Sinica B
- Macrophage expression and prognostic significance of the long pentraxin PTX3 in COVID-19
- (2020) Enrico Brunetta et al. NATURE IMMUNOLOGY
- Apelin Is a Negative Regulator of Angiotensin II–Mediated Adverse Myocardial Remodeling and DysfunctionNovelty and Significance
- (2017) Zhen-Zhou Zhang et al. HYPERTENSION
- Deletion of angiotensin-converting enzyme 2 exacerbates renal inflammation and injury in apolipoprotein E-deficient mice through modulation of the nephrin and TNF-alpha-TNFRSF1A signaling
- (2015) Hai-Yan Jin et al. Journal of Translational Medicine
- Angiotensin-Converting Enzyme 2 Suppresses Pathological Hypertrophy, Myocardial Fibrosis, and Cardiac Dysfunction
- (2010) JiuChang Zhong et al. CIRCULATION
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started